BioCentury | Oct 2, 2020
Distillery Therapeutics

Targeting CXCL1 signaling for HSV-1 encephalitis

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Encephalitis; herpes simplex virus (HSV)Inhibiting CXCL1 or its...
...Hospital Harvard Medical School Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA) CXC chemokine receptor 2 (CXCR2) (IL8RB) Infectious Encephalitis Herpes simplex...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the International Symposium on NeuroVirology meeting in Atlanta showing CRISPR-Cas9 gene editing could treat herpes simplex...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...candidate, ONCR-177, into Phase I testing for solid tumors. The product uses the company’s herpes simplex...
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...response rate from 18% to 38.8% compared with Yervoy alone. Amgen gained Imlygic, a herpes simplex...
...Takara Bio Inc. (JASDAQ:4974) Otsuka Pharmaceutical Co. Ltd. Intratumorally delivered unmodified, attenuated strain of herpes simplex...
BioCentury | Aug 5, 2019
Clinical News

Aug. 5 Clinical Quick Takes: Emgality meets for migraine with treatment failures; plus Verona, Alkahest-Grifols, Squarex and Denali-Sanofi

...LLC Verona Pharma plc Calcitonin gene-related peptide (CGRP) Phosphodiesterase-3 (PDE-3) Phosphodiesterase-4 (PDE-4) Receptor-interacting serine-threonine kinase 1 (RIPK1) (RIP1) Alzheimer's disease (AD) Herpes simplex...
BioCentury | Aug 2, 2019
Clinical News

SillaJen, Transgene fall with latest oncolytic virus setback

...interest in the field. Like Pexa-Vec, T-Vec delivers GM-CSF, but the vaccine is a herpes simplex...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...E3 (VEEV E3) VEEV capsid protein (VEEV C) VEEV 6K protein (VEEV 6K) Encephalitis; herpes simplex...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...CR or PR 3063 University of Michigan Ad-hCMV-TK + Ad-hCMV-Flt3L Adenoviral vectors expressing Human herpes simplex...
BioCentury | May 28, 2019
Distillery Therapeutics

B. fragilis PSA for the prevention of Herpes simplex encephalitis

...DISEASE CATEGORY: Infectious disease INDICATION: Encephalitis; herpes simplex virus (HSV) Mouse studies suggest B. fragilis PSA...
...email: ecantin@coh.org Claire Quang Beckman Research Institute of City of Hope Bacteroides fragilis polysaccharide A (B. fragilis PSA) Herpes simplex...
BioCentury | Dec 5, 2018
Distillery Therapeutics

Cancer

...INDICATION: Brain cancer Mouse studies suggest an oncolytic herpes simplex virus (HSV) expressing CDH1 could help...
Items per page:
1 - 10 of 645
BioCentury | Oct 2, 2020
Distillery Therapeutics

Targeting CXCL1 signaling for HSV-1 encephalitis

...By Claire Quang, Staff Writer DISEASE CATEGORY: Infectious diseaseINDICATION: Encephalitis; herpes simplex virus (HSV)Inhibiting CXCL1 or its...
...Hospital Harvard Medical School Chemokine CXC motif ligand 1 (CXCL1) (GRO) (MGSA) CXC chemokine receptor 2 (CXCR2) (IL8RB) Infectious Encephalitis Herpes simplex...
BioCentury | Nov 22, 2019
Preclinical News

Nov. 21 Preclinical Quick Takes: Excision applies CRISPR editing to herpes, John Cunningham viruses; plus Caribou, Oligomerix, Kymab and Gladstone-Boston Univer

...the International Symposium on NeuroVirology meeting in Atlanta showing CRISPR-Cas9 gene editing could treat herpes simplex...
BioCentury | Aug 21, 2019
Financial News

Oncorus raises $79.5M series B with eye on global development

...candidate, ONCR-177, into Phase I testing for solid tumors. The product uses the company’s herpes simplex...
BioCentury | Aug 8, 2019
Tools & Techniques

Checkpoint inhibitors are bringing oncolytic viruses back into the spotlight

...response rate from 18% to 38.8% compared with Yervoy alone. Amgen gained Imlygic, a herpes simplex...
...Takara Bio Inc. (JASDAQ:4974) Otsuka Pharmaceutical Co. Ltd. Intratumorally delivered unmodified, attenuated strain of herpes simplex...
BioCentury | Aug 5, 2019
Clinical News

Aug. 5 Clinical Quick Takes: Emgality meets for migraine with treatment failures; plus Verona, Alkahest-Grifols, Squarex and Denali-Sanofi

...LLC Verona Pharma plc Calcitonin gene-related peptide (CGRP) Phosphodiesterase-3 (PDE-3) Phosphodiesterase-4 (PDE-4) Receptor-interacting serine-threonine kinase 1 (RIPK1) (RIP1) Alzheimer's disease (AD) Herpes simplex...
BioCentury | Aug 2, 2019
Clinical News

SillaJen, Transgene fall with latest oncolytic virus setback

...interest in the field. Like Pexa-Vec, T-Vec delivers GM-CSF, but the vaccine is a herpes simplex...
BioCentury | Jun 5, 2019
Translation in Brief

New Therapeutic Targets and Biomarkers: May 2019

...E3 (VEEV E3) VEEV capsid protein (VEEV C) VEEV 6K protein (VEEV 6K) Encephalitis; herpes simplex...
BioCentury | Jun 1, 2019
Product Development

ASCO 2019 abstracts show solid tumor race heating up among bispecifics and CAR Ts

...CR or PR 3063 University of Michigan Ad-hCMV-TK + Ad-hCMV-Flt3L Adenoviral vectors expressing Human herpes simplex...
BioCentury | May 28, 2019
Distillery Therapeutics

B. fragilis PSA for the prevention of Herpes simplex encephalitis

...DISEASE CATEGORY: Infectious disease INDICATION: Encephalitis; herpes simplex virus (HSV) Mouse studies suggest B. fragilis PSA...
...email: ecantin@coh.org Claire Quang Beckman Research Institute of City of Hope Bacteroides fragilis polysaccharide A (B. fragilis PSA) Herpes simplex...
BioCentury | Dec 5, 2018
Distillery Therapeutics

Cancer

...INDICATION: Brain cancer Mouse studies suggest an oncolytic herpes simplex virus (HSV) expressing CDH1 could help...
Items per page:
1 - 10 of 645